This week on CUTalks we are talking to Tim Brears, CEO of Evonetix. Evonetix is a synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis. Tim holds a PhD from Cambridge University and has an MBA from Duke University’s Fuqua School of Business. Tim recently led a $30M Series B round. Tim introduced synthetic biology and its immense potential in the industry. He also shared about some strategies that his company used in order to differentiate themselves from the larger players. Tim also talked about his experience raising fund from a different continent i.e. the US, while growing the company in Cambridge, UK. Lastly, Tim gave some career advice for PhD students who might want to work outside of academia.

To find out more about CUTEC, visit https://www.cutec.io/

This podcast was produced by Carl Homer, Cambridge TV.

Ver todos los episodios